ESC Premium Access

Edoxaban Treatment in routiNe clinical prActice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe): 1-year follow-up according to body mass index

Congress Session

About the speaker

Professor Thomas Weiss

University Hospital St. Polten, St. Polten (Austria)
0 follower

7 more presentations in this session

Men who live alone have poor anticoagulation control: results from Danish registries.

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Thumbnail

VTE-BLEED score predicts major bleeding in patients with atrial fibrillation

Speaker: Doctor E. Klok (Leiden, NL)

Thumbnail

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, NJ, US)

Thumbnail

Optimal rivaroxaban dose in asian patients with atrial fibrillation and normal or mildly impaired renal function

Speaker: Doctor E. Choi (Seoul, KR)

Thumbnail

Antithrombotic challenge in the clinical dilemma of high-risk patients with atrial fibrillation: one-year result from ChiOTEAF Registry

Speaker: Professor Y. Guo (Beijing, CN)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 3

Speakers: Professor T. Weiss, Doctor A. Nissen Bonde, Doctor E. Klok, Doctor X. Li, Doctor E. Choi...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk